Page 2 - Giveni Mab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

I-Mab (NASDAQ:IMAB – Get Rating) and Iterum Therapeutics (NASDAQ:ITRM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations. Risk & Volatility I-Mab has a beta of 0.94, indicating […] ....

Kalbe Genexine Biologics , Coreyn Fishman , Abbvie Ireland Unlimited Company , Iterum Therapeutics Plc , Sinopharm Group Co , Get Rating , Iterum Therapeutics , Iterum Therapeutic , Giveni Mab , Sinopharm Group , Genexine Biologics , Therapeutics Plc , I Mab , Nasdaq Imab , Stock Comparison , Stock Analysis ,